Prot# CY 6031 A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of CK3773274 in Adults with Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction

Project: Research project

Project Details

StatusActive
Effective start/end date5/24/225/24/25

Funding

  • Cytokinetics, Inc. (Prot# CY 6031)